NasdaqGS - Nasdaq Real Time Price USD
AN2 Therapeutics, Inc. (ANTX)
1.1900
-0.0200
(-1.65%)
At close: May 19 at 4:00:01 PM EDT
1.1900
0.00
(0.00%)
After hours: May 19 at 4:05:14 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.31 | -0.27 | -1.18 | -0.96 |
| Low Estimate | -0.31 | -0.27 | -1.18 | -0.96 |
| High Estimate | -0.31 | -0.27 | -1.18 | -0.96 |
| Year Ago EPS | -0.48 | -0.35 | -1.65 | -1.18 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.59 | -0.39 | -0.34 | -0.27 |
| EPS Actual | -0.48 | -0.35 | -0.25 | -0.35 |
| Difference | 0.11 | 0.03 | 0.09 | -0.08 |
| Surprise % | 18.99% | 8.97% | 25.88% | -29.63% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.31 | -0.27 | -1.18 | -0.96 |
| 7 Days Ago | -0.22 | -0.28 | -1.21 | -0.98 |
| 30 Days Ago | -0.23 | -0.25 | -0.95 | -1.03 |
| 60 Days Ago | -0.24 | -0.31 | -1.44 | -1.09 |
| 90 Days Ago | -0.25 | -0.27 | -1.25 | -1.02 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | 1 | 1 | 2 | -- |
| Down Last 7 Days | -- | -- | 1 | 1 |
| Down Last 30 Days | -- | -- | 1 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ANTX | 35.42% | 23.30% | 28.30% | 18.64% |
| S&P 500 | 13.32% | 2.67% | 7.78% | 13.75% |
Upgrades & Downgrades
| Maintains | JMP Securities: Market Outperform to Market Outperform | 5/5/2025 |
| Reiterates | Citizens Capital Markets: Market Outperform to Market Outperform | 3/26/2025 |
| Reiterates | Citizens Capital Markets: Market Outperform to Market Outperform | 2/25/2025 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 2/3/2025 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 11/19/2024 |
| Downgrade | TD Cowen: Buy to Hold | 11/18/2024 |
Related Tickers
HLVX HilleVax, Inc.
1.9500
-1.02%
TBPH Theravance Biopharma, Inc.
9.39
+2.07%
PRTC.L PureTech Health plc
128.00
-2.14%
PMVP PMV Pharmaceuticals, Inc.
0.8740
+0.94%
BOLT Bolt Biotherapeutics, Inc.
0.3277
+11.84%
IKNA Ikena Oncology, Inc.
1.1100
0.00%
KZR Kezar Life Sciences, Inc.
4.0300
-0.98%
RPTX Repare Therapeutics Inc.
1.3800
+2.99%
EPIX ESSA Pharma Inc.
1.7000
-0.58%
CRGX CARGO Therapeutics, Inc.
4.0900
-0.73%